Patient presents with jaundice, characterized by yellowing of the skin and sclera.  Differential diagnosis includes neonatal jaundice, obstructive jaundice, hemolytic jaundice, and hepatocellular jaundice.  Assessment focuses on identifying the underlying etiology, considering risk factors such as age, medication history including acetaminophen and statins, family history of liver disease, alcohol consumption, recent infections like hepatitis, and exposure to toxins.  Physical examination reveals icterus, and may include hepatomegaly, splenomegaly, or abdominal tenderness.  Laboratory tests, including total bilirubin, direct bilirubin, indirect bilirubin, liver function tests (LFTs) such as AST, ALT, ALP, and GGT, complete blood count (CBC), and coagulation studies, are essential for diagnosis and monitoring.  Imaging studies, like abdominal ultrasound, CT scan, or MRI, may be indicated to evaluate liver and biliary tract anatomy.  Treatment for jaundice depends on the underlying cause and may include phototherapy for neonatal jaundice, endoscopic retrograde cholangiopancreatography (ERCP) for biliary obstruction, or medications to manage underlying liver disease.  Patient education regarding lifestyle modifications, dietary restrictions, and medication adherence is crucial.  ICD-10 codes for jaundice may include R17 (jaundice, unspecified), R18 (other jaundice), or more specific codes based on the underlying cause.  CPT codes for diagnostic and treatment procedures will be documented based on services rendered.  Follow-up is essential to monitor bilirubin levels, liver function, and treatment response.